'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCC
- PMID: 36627186
- DOI: 10.1136/gutjnl-2022-329099
'Invisible' immune checkpoint molecule causing resistance to anti-PD1 therapy in HCC
Keywords: hepatobiliary cancer; immunotherapy.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.Gut. 2023 Aug;72(8):1568-1580. doi: 10.1136/gutjnl-2022-327133. Epub 2022 Nov 30. Gut. 2023. PMID: 36450387
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical